Mdm2 Targeting Reassembly Peptide (Trap) Nanoparticles for P53 Based Cancer Therapy

Investigators developed ARF-mimetic MDM2-targeting reassembly peptide nanoparticles (MtrapNPs) for p53-based tumor therapy. They elucidated that the MtrapNPs responded to and formed a nanofiber structure with MDM2.